ScreenerHero
BIIBBiogen Inc.
NAS · US · Healthcare · Drug Manufacturers - General · biogen.com
199.71USD+1.59%Mkt Cap: 29.48B $P/E: 21.47

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple…

Industry Peers

Drug Manufacturers - General
Screen all
vs Drug Manufacturers - General
P/E
Avg
P/B
Cheaper
1M Perf
Lower
LLY
Eli Lilly and Company
$982.77BUSDP/E 39.2
+832.4% 1M
JNJ
Johnson & Johnson
$556.77BUSDP/E 26.8
+85.9% 1M
ABBV
AbbVie Inc.
$406.29BUSDP/E 112.7
+834.2% 1M
RO
Roche Holding AG
$294.39BUSDP/E 20.2
-316.6% 1M
NOVNEE
Novartis AG
$267.10BUSDP/E 21.4
+82.1% 1M
MRK
Merck & Co., Inc.
$285.22BUSDP/E 32.5
+217.7% 1M
NOVN
Novartis AG
$261.94BUSDP/E 21.6
+87.2% 1M
AZN
AstraZeneca PLC
$251.74BUSDP/E 26.7
-398.9% 1M
AZN
AstraZeneca PLC
$224.03BUSDP/E 26.4
-511.2% 1M
NOVO-B
Novo Nordisk A/S
$193.45BUSDP/E 10.9
+400.5% 1M
AMGN
Amgen Inc.
$186.05BUSDP/E 24.0
+396.6% 1M
GILD
Gilead Sciences, Inc.
$155.03BUSDP/E 17.0
-445.3% 1M
PFE
Pfizer Inc.
$142.94BUSDP/E 19.1
-275.3% 1M
BMY
Bristol-Myers Squibb Company
$111.70BUSDP/E 15.3
-656.0% 1M
SAN
Sanofi
$94.31BUSDP/E 18.3
-567.1% 1M
GSK
GSK plc
$83.84BUSDP/E 13.6
+52.2% 1M
BAYN
Bayer Aktiengesellschaft
$40.77BUSD
-187.6% 1M
MRV
Marvell Technology, Inc.
$32.03BUSDP/E 12.2
+5682.2% 1M
REC
Recordati Industria Chimica e Farmaceutica S.p.A.
$11.28BUSDP/E 22.6
-58.5% 1M
ORNBV
Orion Oyj
$10.49BUSDP/E 18.2
-372.4% 1M
ORNAV
Orion Oyj
$10.49BUSDP/E 18.2
-338.5% 1M
GRF
Grifols, S.A.
$6.69BUSDP/E 14.8
-475.9% 1M
OGN
Organon & Co.
$3.52BUSDP/E 14.4
-44.6% 1M
VIRP
Virbac SA
$3.08BUSDP/E 18.8
-583.3% 1M
SCLX
Scilex Holding Company
$48.32MUSD
+1431.0% 1M
MIRA
MIRA Pharmaceuticals, Inc.
$39.98MUSD
-170.4% 1M
ELXR
Elixxer Ltd.
$9.51MUSD
+1666.7% 1M
ROSE
DocMorris AG
—
+1809.0% 1M
CELG-RI
Bristol-Myers Squibb Company Ce
—
FLXN
Horizon Flexible Income ETF
—P/E 27.4
+30.1% 1M
PHOO
Photocure ASA
—
FR0000140022
SANOFITP29OCT49
—
Indicators:|

Key Statistics

Company
Market Cap29.48B $
Enterprise Value31.30B $
Revenue (TTM)9.94B $
Gross Profit7.49B $
Net Income (TTM)1.29B $
Revenue/Share67.70 USD
Last Price199.71 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7.5K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS09062X1037
Valuation
P/E (Trailing)21.47
P/E (Forward)11.82
PEG3.94
EV/EBITDA8.84
EV/Revenue3.15
P/S2.92
P/B1.56
EPS (TTM)9.30
EPS (Forward)16.62
52W Range
121.0593% of range205.97
52W High205.97 USD
52W Low121.05 USD
Profitability
Gross Margin75.69%
Oper. Margin22.90%
EBITDA Margin35.62%
Profit Margin13.07%
ROE7.08%
ROA4.39%
Growth
Revenue Growth1.90%
Earnings Growth31.10%
Cash Flow & Leverage
Operating CF2.20B $
CapEx (TTM)235.40M $
FCF Margin19.43%
FCF Yield6.55%
Net Debt2.28B $
Net Debt/EBITDA0.64
Balance Sheet
Debt/Equity0.36
Current Ratio3.06
Quick Ratio2.02
Book Value/Sh126.37 USD
Cash/Share29.01 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split3:1
Split DateJan 18, 2001
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)220.25 USD
Upside (mean)+10.3%
Target Range150.00 USD – 300.00 USD
$150.00+10.3% to mean$300.00
# Analysts31
Ownership
Shares Out.147.64M
Float147.18M
Insiders0.19%
Institutions96.23%
Short Interest
Short Ratio4.0d
Short % Float3.60%
Short % Out.3.23%
Shares Short4.77M
Short (prev mo.)4.48M
Technical
SMA 50190.48 (+4.8%)
SMA 200174.70 (+14.3%)
Beta0.18
S&P 52W Chg24.49%
Avg Vol (30d)998.19K
Avg Vol (10d)1.05M
Technical Indicators
RSI (14)55.8
MACD1.9124
MACD Signal1.9296
MACD Hist.-0.0172
BB Upper202.02 USD
BB Middle196.26 USD
BB Lower190.50 USD
BB Width5.87%
ATR (14)6.087 USD
Vol Ratio (20d)1.99x